desmopressin acetate

desmopressin acetate (MINIRIN) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: oral. Current US regulatory status: approved.

MINIRIN is a marketed brand name for desmopressin acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

desmopressin acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.